BSECompany Update12h ago · 31 Aug 2026, 04:29 pm
Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.
Global Health Ltd · 543654
✦ AI SummaryMgmt Change
Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet on September 8, 2026, in Gurugram, with no unpublished price sensitive information to be shared.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
accaff4f-cb6a-4f25-9537-6f318aadc6a9.pdf
View document text
August 31, 2026
Ref:- GHL/2026-27/EXCH/ 49
The General Manager The Manager
Dept. of Corporate Services Listing Department
BSE Limited, National Stock Exchange of India Limited
P J Towers, Dalal Street, Exchange Plaza, C-1, Block G,
Mumbai - 400 001 Bandra Kurla Complex,
Bandra (E), Mumbai - 400 051
Scrip Code: 543654 Symbol: MEDANTA
Sub: Intimation for Schedule of Analysts/Institutional Investors Meeting.
Dear Sir(s),
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will
meet Investors/Analysts as per the below schedule:
Date of Meeting Name of Investor/Analyst Type of Place of Meeting Mode of
Firm Meeting Meeting
September 8, Matthews International One to One Gurugram In person
2026 Capital Management
September 8, Baillie Gifford One to One Gurugram In person
2026
Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat.
Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances,
on the part of Analysts/Investors/Company.
Kindly take the above on record.
For Global Health Limited
Rahul Ranjan
Company Secretary & Compliance Officer
M.No. A17035
Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319